Wendy Browning
Global Commodity Manager ‘ͺ Molecular Diagnostics
As Global Commodity Manager — Molecular Diagnostics for ΎΕ²© Healthcare, Wendy Browning serves the division's customers with supply chain operations and sourcing expertise across a range of precision medicine product applications, including liquid biopsy, next-generation sequencing (NGS), companion diagnostics (CDx) and molecular point-of-care testing (MDxT).
In her cross-sector role, Wendy has established prime supplier relationships with the industry's best to minimize risk, optimize results and collaboratively define commercialization strategies — from ideation to development and delivery of testing advancements — that improve patient outcomes across a range of care delivery settings.
Wendy's focus on strategic qualification for alternative materials and sourcing of supply adhering to ISO 13485 medical device regulations has been instrumental in establishing ΎΕ²© Healthcare as a trusted, end-to-end reagent solutions provider with specialized capabilities for IVD medical device production and manufacturing.
Prior to joining ΎΕ²© in 2020, Wendy directed procurement and supply chain strategy for leading biotechnology and clinical research foundations. Based out of ΎΕ²©'s Auburn Hills, Michigan, facility, Wendy earned a Bachelor of Science in Genomics and Molecular Genetics from Michigan State University.
